Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines

Journal of Bone and Mineral Research

Volumn 21, Issue 8, 2006, Pages 1307-1316

  Matsuzaki, Etsuko ^a,b   Takahashi Yanaga, Fumi ^a   Miwa, Yoshikazu ^a   Hirata, Masato ^b   Watanabe, Yutaka ^c   Sato, Noriharu ^d   Morimoto, Sachio ^a   Hirofuji, Takao ^e   Maeda, Katsumasa ^b   Sasaguri, Toshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c EHIME UNIVERSITY   (Japan)

^d THE UNIVERSITY OF TOKYO   (Japan)

^e FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

catenin; Alkaline phosphatase; Differentiation inducing factor 1; Osteoblast; T cell factor lymphoid enhancer binding factor; Wnt

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; COLLAGEN TYPE 1; DIFFERENTIATION INDUCING FACTOR; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCER FACTOR 1; OSTEOCALCIN; T CELL FACTOR PROTEIN; WNT1 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; DECHLORINATION; DICTYOSTELIUM; GENE ACTIVITY; MAMMAL CELL; MINERALIZATION; NONHUMAN; OSTEOBLAST; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FAMILY; REPORTER GENE;

ALKALINE PHOSPHATASE; ANIMALS; BETA CATENIN; BINDING SITES; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL PROLIFERATION; HEXANONES; HUMANS; HYDROCARBONS, CHLORINATED; LYMPHOID ENHANCER-BINDING FACTOR 1; MICE; OSTEOBLASTS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SIGNAL TRANSDUCTION; T CELL TRANSCRIPTION FACTOR 1; WNT PROTEINS;

EID: 33746444964     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060512     Document Type: Article

References (50)

1. Morris HR, Taylor GW, Masento MS, Jermyn KA, Kay RR 1987 Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature 328:811-814.
2. Morris HR, Masento MS, Taylor GW, Jermyn KA, Kay RR 1988 Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum. Biochem J 249:903-906.
3. 1 arrest and differentiation of vascular smooth muscle cells. Circ Res 86:68-75.
4. Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, Moromoto S, Sasaguri T 2003 Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3β and degrades cyclin D1 in mammalian cells. J Biol Chem 278:9663-9670.
5. 286 in squamous cell carcinoma. Exp Cell Res 310:426-433.
6. Bejsovec A 2000 Wnt signaling: An embarrassment of receptors. Curr Biol 10:R919-R922.
7. Moon RT, Brown JD, Torres M 1997 WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13:157-162.
8. Nusse R 1999 WNT targets. Repression and activation. Trends Genet 15:1-3.
9. 2+ pathways. Oncogene 18:7860-7872.
10. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W 1996 Functional interaction of β-catenin with the transcriptional factor LEF-1. Nature 382:638-642.
11. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Juppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, La Combe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523.
12. Kato M, Patel MS, Levasseur R, Lobov I, Chang BHJ, Glass DA II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314.
13. Ai M, Heeger S, Bartels CF, Schelling DI, Osteoporosis-Pseudoglioma Collaborative Group 2005 Clinical and molecular findings in osteoporosis- pseudoglioma syndrome. Am J Hum Genet 77:741-753.
14. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP 2002 High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513-1521.
15. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao S, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Eerdewegh PV, Recker RR, Johnson ML 2002 A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
16. Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S 2003 BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18:1842-1853.
17. Masento MS, Morris HR, Taylor GW, Johnson SJ, Skapski AC, Kay RR 1988 Differentiation- inducing factor from the slime mould Dictyostelium discoideum and its analogues: Synthesis, structure and biological activity. Biochem J 256:23-28.
18. Uehara R, Suzuki Y, Ichikawa Y 2001 Methotrexate (MTX) inhibits osteoblastic differentiation in vitro: Possible mechanism of MTX osteopathy. J Rheumatol 28:251-256.
19. Sasaguri T, Ishida A, Kosaka C, Nojima H, Ogata J 1996 Phorbol ester inhibits the phosphorylation of the retinoblastoma protein without suppressing cyclin D-associated kinase in vascular smooth muscle cells. J Biol Chem 271:8345-8351.
20. Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem 272:10050-10057.
21. Yusa N, Watanabe K, Yoshida S, Shirafuji N, Shimomura S, Tani K, Asano S, Sato N 2000 Transcription factor Sp3 activates the liver/bone/kidney-type alkaline phosphatase promoter in hematopoietic cells. J Leukoc Biol 68:772-777.
22. Weiss MJ, Ray K, Henthorn PS, Lamb B, Kadesch T. Harris H 1988 Structure of the human liver/bone/kidney alkaline phosphatase gene. J Biol Chem 263:12002-12010.
23. Oosterwegel MA, van de Wetering ML, Holstege FC, Prosser HM, Owen MJ, Clevers HC 1991 TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCRβ and TCRδ enhancers. Int Immunol 11:1189-1192.
24. Oosterwegel M, van de Wetering M, Dooijes D, Klomp L, Winoto A, Georgopoulos K, Meijlink F, Clevers H 1991 Cloning of Murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-ε and T cell receptor α enhancers. J Exp Med 173:1133-1142.
25. Horton RM 1993 In vitro recombination and mutagenesis of DNA. In: Methods in Molecular Biology, vol. 15. Humana Press, Totowa, NJ, USA, pp. 251-261.
26. Asahi K, Sakurai A, Takahashi N, Kubohara Y, Okamoto K, Tanaka Y 1995 DIF-1, morphogen of Dictyostelium discoideum, induces the erythroid differentiation in murine and human leukemia cells. Biochem Biophys Res Commun 208:1036-1039.
27. Kubohara Y 1997 DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60. Biochem Biophys Res Commun 236:418-422.
28. Kubohara Y 1999 Effects of differentiation-inducing factors of Dictyostelium discoideum on human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent. Eur J Pharmacol 381:57-62.
29. Aubin JE 1998 Bone stem cells. J Cell Biochem 30-31:73-82. [Suppl]
30. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
31. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ 1997 Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
32. Bain G, Muller T, Wang X, Papkoff J 2003 Activated β-catenin induces osteoblast differentiation of C3H10T1/2 cells and participates in BMP2 mediated signal transduction. Biochem Biophys Res Commun 301:84-91.
33. Hongliang H, Hilton MJ, Tu X, Yu K, Ornitz DM, Long F 2005 Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132:49-60.
34. Ferkey DM, Kimelman D 2000 GSK-3: New thoughts on an old enzyme. Dev Biol 225:471-479.
35. Kim L, Kimmel AR 2000 GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr Opin Genet Dev 10:508-514.
36. Harwood AJ 2001 Regulation of GSK-3: A cellular multiprocessor. Cell 105:821-824.
37. Yasmin T, Takahashi-Yanaga F, Mori J, Miwa Y, Hirata M, Watanabe Y, Morimoto S, Sasaguri T 2005 Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells. Biochem Biophys Res Commun 338:903-909.
38. Jackson A, Vayssiere B, Garcia T, Newell W, Baron R, Roman-Roman S, Rawadi G 2005 Gene array analysis of Wnt-regulated genes in C3H10T1/2 cells. Bone 36:585-598.
39. Labbe E, Letamendia A, Attisano L 2000 Association of Smads with lymphoid enhancer binding factor IAT cell-specific factor mediates cooperative signaling by the transforming factor-β and Wnt pathways. Proc Natl Acad Sci USA 97:8358-8363.
40. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW 2000 Interaction between Wnt and TGF-β signaling pathways during formation of Spemann's organizer. Nature 403:781-785.
41. Hussein SM, Duff EK, Sirard C 2003 Smad4 and β-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278:48805-48814.
42. Nelson WJ, Nusse R 2004 Convergence of Wnt, β-catenin, and cadherin pathways. Science 303:1483-1487.
43. Polakis P 2000 Wnt signaling and cancer. Genes Dev 14:1837-1851.
44. Povelones M, Nusse R 2002 Wnt signaling sees spots. Nat Cell Biol 4:E249-E250.
45. Dale TC 1998 Signal trasduction by the Wnt family of ligands. Biochem J 329:209-223.
46. Tetsu O, McCormick F 1999 β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
47. Shimizu K, Murata T, Tagawa T, Takahashi K, Ishikawa R, Abe Y, Hosaka K, Kubohara Y 2004 Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium. Cancer Res 64:2568-2571.
48. Shih IM, Yu J, He TC, Vogelstein B, Kinzler KW 2000 The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression. Cancer Res 60:1671-1676.
49. Kakkar R, Raju RV, Sharma RK 1999 Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1). Cell Mol Life Sci 55:1164-1186.
50. Lerner A, Kim DH, Lee R 2000 The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Leuk Lymphoma 37:39-51.